Advertisement

Mapping the Androgen Receptor Cistrome

  • Qianben Wang
  • Myles Brown
Chapter

Abstract

Androgen receptor (AR) is a ligand-dependent transcription factor that plays a key role in prostate cancer. Mapping the AR cistrome (cis-targets of a trans-acting factor across the genome) by ChIP-on-chip (chromatin immunoprecipitation on a microarray) discovers that the majority of AR-binding regions is far from the promoters of AR target genes and contains noncanonical AR responsive elements (ARE). Importantly, a noncanonical ARE is served as a cis-regulatory target of AR action in TMPRSS2, a gene fused to ETS transcription factors in the majority of prostate cancers. In addition other DNA sequence motifs are significantly enriched within the AR-binding regions and are bound by cooperating transcription factors FoxA1, GATA2, Oct1, and ETS1. These transcription factors cooperate in mediating the androgen response and offer potential new opportunities for therapeutic intervention.

Keywords

Androgen Receptor LNCaP Cell Nuclear Hormone Receptor Androgen Receptor Binding Androgen Receptor Target 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

We thank Drs. Jason Carroll, Timothy Geistlinger, and Wei Li for critical reading of the manuscript.

reference

  1. Balk, S.P. 2002. Androgen receptor as a target in androgen-independent prostate cancer. Urology 60: 132–8; discussion 138–9.PubMedGoogle Scholar
  2. Barettino, D., M.M. Vivanco Ruiz, and H.G. Stunnenberg. 1994. Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor. EMBO J 13: 3039–49.PubMedGoogle Scholar
  3. Barski, A., S. Cuddapah, K. Cui, T.Y. Roh, D.E. Schones, Z. Wang, G. Wei, I. Chepelev, and K. Zhao. 2007. High-resolution profiling of histone methylations in the human genome. Cell 129: 823–37.PubMedGoogle Scholar
  4. Blackwood, E.M. and J.T. Kadonaga. 1998. Going the distance: a current view of enhancer action. Science 281: 61–3.Google Scholar
  5. Bolton, E.C., A.Y. So, C. Chaivorapol, C.M. Haqq, H. Li, and K.R. Yamamoto. 2007. Cell- and gene-specific regulation of primary target genes by the androgen receptor. Genes Dev 21: 2005–17.PubMedGoogle Scholar
  6. Boyes, J., P. Byfield, Y. Nakatani, and V. Ogryzko. 1998. Regulation of activity of the transcription factor GATA-1 by acetylation. Nature 396: 594–8.PubMedGoogle Scholar
  7. Bruggemeier, U., M. Kalff, S. Franke, C. Scheidereit, and M. Beato. 1991. Ubiquitous transcription factor OTF-1 mediates induction of the MMTV promoter through synergistic interaction with hormone receptors. Cell 64: 565–72.PubMedGoogle Scholar
  8. Bulger, M. and M. Groudine. 1999. Looping versus linking: toward a model for long-distance gene activation. Genes Dev 13: 2465–77.PubMedGoogle Scholar
  9. Carroll, J.S., X.S. Liu, A.S. Brodsky, W. Li, C.A. Meyer, A.J. Szary, J. Eeckhoute, W. Shao, E.V. Hestermann, T.R. Geistlinger, E.A. Fox, P.A. Silver, and M. Brown. 2005. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122: 33–43.PubMedGoogle Scholar
  10. Carroll, J.S., C.A. Meyer, J. Song, W. Li, T.R. Geistlinger, J. Eeckhoute, A.S. Brodsky, E.K. Keeton, K.C. Fertuck, G.F. Hall, Q. Wang, S. Bekiranov, V. Sementchenko, E.A. Fox, P.A. Silver, T.R. Gingeras, X.S. Liu, and M. Brown. 2006. Genome-wide analysis of estrogen receptor binding sites. Nat Genet 38: 1289–97.PubMedGoogle Scholar
  11. Cawley, S., S. Bekiranov, H.H. Ng, P. Kapranov, E.A. Sekinger, D. Kampa, A. Piccolboni, V. Sementchenko, J. Cheng, A.J. Williams, R. Wheeler, B. Wong, J. Drenkow, M. Yamanaka, S. Patel, S. Brubaker, H. Tammana, G. Helt, K. Struhl, and T.R. Gingeras. 2004. Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 116: 499–509.PubMedGoogle Scholar
  12. Cirillo, L.A., C.E. McPherson, P. Bossard, K. Stevens, S. Cherian, E.Y. Shim, K.L. Clark, S.K. Burley, and K.S. Zaret. 1998. Binding of the winged-helix transcription factor HNF3 to a linker histone site on the nucleosome. EMBO J 17: 244–54.PubMedGoogle Scholar
  13. Cirillo, L.A., F.R. Lin, I. Cuesta, D. Friedman, M. Jarnik, and K.S. Zaret. 2002. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol Cell 9: 279–89.PubMedGoogle Scholar
  14. Clark, K.L., E.D. Halay, E. Lai, and S.K. Burley. 1993. Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature 364: 412–20.PubMedGoogle Scholar
  15. Danielian, P.S., R. White, J.A. Lees, and M.G. Parker. 1992. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors [published erratum appears in EMBO J 1992 11(6): 2366]. EMBO J 11: 1025–33.PubMedGoogle Scholar
  16. Debes, J.D. and D.J. Tindall. 2004. Mechanisms of androgen-refractory prostate cancer. N Engl J Med 351: 1488–90.PubMedGoogle Scholar
  17. Dekker, J., K. Rippe, M. Dekker, and N. Kleckner. 2002. Capturing chromosome conformation. Science 295: 1306–11.PubMedGoogle Scholar
  18. DePrimo, S.E., M. Diehn, J.B. Nelson, R.E. Reiter, J. Matese, M. Fero, R. Tibshirani, P.O. Brown, and J.D. Brooks. 2002. Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol 3: RESEARCH0032PubMedGoogle Scholar
  19. Dostie, J. and J. Dekker. 2007. Mapping networks of physical interactions between genomic elements using 5C technology. Nat Protoc 2: 988–1002.PubMedGoogle Scholar
  20. Dostie, J., T.A. Richmond, R.A. Arnaout, R.R. Selzer, W.L. Lee, T.A. Honan, E.D. Rubio, A. Krumm, J. Lamb, C. Nusbaum, R.D. Green, and J. Dekker. 2006. Chromosome Conformation Capture Carbon Copy (5C): a massively parallel solution for mapping interactions between genomic elements. Genome Res 16: 1299–309.PubMedGoogle Scholar
  21. Eder, I.E., J. Hoffmann, H. Rogatsch, G. Schafer, D. Zopf, G. Bartsch, and H. Klocker. 2002. Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor. Cancer Gene Ther 9: 117–25.PubMedGoogle Scholar
  22. Eeckhoute, J., E.K. Keeton, M. Lupien, S.A. Krum, J.S. Carroll, and M. Brown. 2007. Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer. Cancer Res 67: 6477–83.PubMedGoogle Scholar
  23. Evans, R.M. 1988. The steroid and thyroid hormone receptor superfamily. Science 240: 889–95.PubMedGoogle Scholar
  24. Fisher, D.A., J.F. Smith, J.S. Pillar, S.H. St Denis, and J.B. Cheng. 1998. Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase. J Biol Chem 273: 15559–64.PubMedGoogle Scholar
  25. Friedman, J.R. and K.H. Kaestner. 2006. The Foxa family of transcription factors in development and metabolism. Cell Mol Life Sci 63: 2317–28.PubMedGoogle Scholar
  26. Gao, N., J. Zhang, M.A. Rao, T.C. Case, J. Mirosevich, Y. Wang, R. Jin, A. Gupta, P.S. Rennie, and R.J. Matusik. 2003. The role of hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes. Mol Endocrinol 17: 1484–507.PubMedGoogle Scholar
  27. Gonzalez, M.I. and D.M. Robins. 2001. Oct-1 preferentially interacts with androgen receptor in a DNA-dependent manner that facilitates recruitment of SRC-1. J Biol Chem 276: 6420–8.PubMedGoogle Scholar
  28. Green, S. and P. Chambon. 1988. Nuclear receptors enhance our understanding of transcription regulation. Trends Genet 4: 309–14.PubMedGoogle Scholar
  29. Gruvberger, S., M. Ringner, Y. Chen, S. Panavally, L.H. Saal, A. Borg, M. Ferno, C. Peterson, and P.S. Meltzer. 2001. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res 61: 5979–84.PubMedGoogle Scholar
  30. Guipponi, M., H.S. Scott, J. Kudoh, K. Kawasaki, K. Shibuya, A. Shintani, S. Asakawa, H. Chen, M.D. Lalioti, C. Rossier, S. Minoshima, N. Shimizu, and S.E. Antonarakis. 1998. Identification and characterization of a novel cyclic nucleotide phosphodiesterase gene (PDE9A) that maps to 21q22.3: alternative splicing of mRNA transcripts, genomic structure and sequence. Hum Genet 103: 386–92.PubMedGoogle Scholar
  31. Haag, P., J. Bektic, G. Bartsch, H. Klocker, and I.E. Eder. 2005. Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells. J Steroid Biochem Mol Biol 96: 251–8.PubMedGoogle Scholar
  32. Hardison, R.C. 2000. Conserved noncoding sequences are reliable guides to regulatory elements. Trends Genet 16: 369–72.PubMedGoogle Scholar
  33. Heinlein, C.A. and C. Chang. 2004. Androgen receptor in prostate cancer. Endocr Rev 25: 276–308.PubMedGoogle Scholar
  34. Hollenberg, S.M., C. Weinberger, E.S. Ong, G. Cerelli, A. Oro, R. Lebo, E.B. Thompson, M.G. Rosenfeld, and R.M. Evans. 1985. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318: 635–41.PubMedGoogle Scholar
  35. Horike, S., S. Cai, M. Miyano, J.F. Cheng, and T. Kohwi-Shigematsu. 2005. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat Genet 37: 31–40.PubMedGoogle Scholar
  36. Hsu, T., M. Trojanowska, and D.K. Watson. 2004. Ets proteins in biological control and cancer. J Cell Biochem 91: 896–903.PubMedGoogle Scholar
  37. Jariwala, U., J. Prescott, L. Jia, A. Barski, S. Pregizer, J.P. Cogan, A. Arasheben, W.D. Tilley, H.I. Scher, W.L. Gerald, G. Buchanan, G.A. Coetzee, and B. Frenkel. 2007. Identification of novel androgen receptor target genes in prostate cancer. Mol Cancer 6: 39.PubMedGoogle Scholar
  38. Jia, L., C.S. Choong, C. Ricciardelli, J. Kim, W.D. Tilley, and G.A. Coetzee. 2004. Androgen receptor signaling: mechanism of interleukin-6 inhibition. Cancer Res 64: 2619–26.PubMedGoogle Scholar
  39. Johnson, D.S., A. Mortazavi, R.M. Myers, and B. Wold. 2007. Genome-wide mapping of in vivo protein–DNA interactions. Science 316: 1497–502.PubMedGoogle Scholar
  40. Kaestner, K.H., W. Knochel, and D.E. Martinez. 2000. Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev 14: 142–6.PubMedGoogle Scholar
  41. Kang, Z., O.A. Janne, and J.J. Palvimo. 2004. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor. Mol Endocrinol 18: 2633–48.PubMedGoogle Scholar
  42. Kato, S., H. Endoh, Y. Masuhiro, T. Kitamoto, S. Uchiyama, H. Sasaki, S. Masushige, Y. Gotoh, E. Nishida, H. Kawashima, et al. 1995. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270: 1491–4.PubMedGoogle Scholar
  43. Kaufmann, E. and W. Knochel. 1996. Five years on the wings of fork head. Mech Dev 57: 3–20.PubMedGoogle Scholar
  44. Kutoh, E., P.E. Stromstedt, and L. Poellinger. 1992. Functional interference between the ubiquitous and constitutive octamer transcription factor 1 (OTF-1) and the glucocorticoid receptor by direct protein–protein interaction involving the homeo subdomain of OTF-1. Mol Cell Biol 12: 4960–9.PubMedGoogle Scholar
  45. Lacroix, M. and G. Leclercq. 2004. About GATA3, HNF3A, and XBP1, three genes co-expressed with the oestrogen receptor-alpha gene (ESR1) in breast cancer. Mol Cell Endocrinol 219: 1–7.PubMedGoogle Scholar
  46. Laganiere, J., G. Deblois, C. Lefebvre, A.R. Bataille, F. Robert, and V. Giguere. 2005. From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. Proc Natl Acad Sci U S A 102: 11651–6.PubMedGoogle Scholar
  47. Lakshmanan, G., K.H. Lieuw, K.C. Lim, Y. Gu, F. Grosveld, J.D. Engel, and A. Karis. 1999. Localization of distant urogenital system-, central nervous system-, and endocardium-specific transcriptional regulatory elements in the GATA-3 locus. Mol Cell Biol 19: 1558–68.PubMedGoogle Scholar
  48. Lapointe, J., C. Li, J.P. Higgins, M. van de Rijn, E. Bair, K. Montgomery, M. Ferrari, L. Egevad, W. Rayford, U. Bergerheim, P. Ekman, A.M. DeMarzo, R. Tibshirani, D. Botstein, P.O. Brown, J.D. Brooks, and J.R. Pollack. 2004. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci U S A 101: 811–6.PubMedGoogle Scholar
  49. Lemon, B. and R. Tjian. 2000. Orchestrated response: a symphony of transcription factors for gene control. Genes Dev 14: 2551–69.PubMedGoogle Scholar
  50. Liao, X., S. Tang, J.B. Thrasher, T.L. Griebling, and B. Li. 2005. Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer. Mol Cancer Ther 4: 505–15.PubMedGoogle Scholar
  51. Louie, M.C., H.Q. Yang, A.H. Ma, W. Xu, J.X. Zou, H.J. Kung, and H.W. Chen. 2003. Androgen-induced recruitment of RNA polymerase II to a nuclear receptor-p160 coactivator complex. Proc Natl Acad Sci U S A 100: 2226–30.PubMedGoogle Scholar
  52. Lowry, J.A. and W.R. Atchley. 2000. Molecular evolution of the GATA family of transcription factors: conservation within the DNA-binding domain. J Mol Evol 50: 103–15.PubMedGoogle Scholar
  53. Luisi, B.F., W.X. Xu, Z. Otwinowski, L.P. Freedman, K.R. Yamamoto, and P.B. Sigler. 1991. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352: 497–505.PubMedGoogle Scholar
  54. Mangelsdorf, D.J. and R.M. Evans. 1995. The RXR heterodimers and orphan receptors. Cell 83: 841–50.PubMedGoogle Scholar
  55. Mangelsdorf, D.J., C. Thummel, M. Beato, P. Herrlich, G. Schutz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, et al. 1995. The nuclear receptor superfamily: the second decade. Cell 83: 835–9.PubMedGoogle Scholar
  56. Massie, C.E., B. Adryan, N.L. Barbosa-Morais, A.G. Lynch, M.G. Tran, D.E. Neal, and I.G. Mills. 2007. New androgen receptor genomic targets show an interaction with the ETS1 transcription factor. EMBO Rep 8: 871–8.PubMedGoogle Scholar
  57. McKenna, N.J. and B.W. O'Malley. 2002. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108: 465–74.PubMedGoogle Scholar
  58. Miesfeld, R., S. Rusconi, P.J. Godowski, B.A. Maler, S. Okret, A.C. Wikstrom, J.A. Gustafsson, and K.R. Yamamoto. 1986. Genetic complementation of a glucocorticoid receptor deficiency by expression of cloned receptor cDNA. Cell 46: 389–99.PubMedGoogle Scholar
  59. Mikkelsen, T.S., M. Ku, D.B. Jaffe, B. Issac, E. Lieberman, G. Giannoukos, P. Alvarez, W. Brockman, T.K. Kim, R.P. Koche, W. Lee, E. Mendenhall, A. O'Donovan, A. Presser, C. Russ, X. Xie, A. Meissner, M. Wernig, R. Jaenisch, C. Nusbaum, E.S. Lander, and B.E. Bernstein. 2007. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448: 553–60.PubMedGoogle Scholar
  60. Molkentin, J.D. 2000. The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression. J Biol Chem 275: 38949–52.PubMedGoogle Scholar
  61. Nagpal, S., M. Saunders, P. Kastner, B. Durand, H. Nakshatri, and P. Chambon. 1992. Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors. Cell 70: 1007–19.PubMedGoogle Scholar
  62. Nelson, P.S., N. Clegg, H. Arnold, C. Ferguson, M. Bonham, J. White, L. Hood, and B. Lin. 2002. The program of androgen-responsive genes in neoplastic prostate epithelium. Proc Natl Acad Sci U S A 99: 11890–5.PubMedGoogle Scholar
  63. Nemer, G. and M. Nemer. 2001. Regulation of heart development and function through combinatorial interactions of transcription factors. Ann Med 33: 604–10.PubMedGoogle Scholar
  64. Oettgen, P., E. Finger, Z. Sun, Y. Akbarali, U. Thamrongsak, J. Boltax, F. Grall, A. Dube, A. Weiss, L. Brown, G. Quinn, K. Kas, G. Endress, C. Kunsch, and T.A. Libermann. 2000. PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression. J Biol Chem 275: 1216–25.PubMedGoogle Scholar
  65. Palvimo, J.J., P. Reinikainen, T. Ikonen, P.J. Kallio, A. Moilanen, and O.A. Janne. 1996. Mutual transcriptional interference between RelA and androgen receptor. J Biol Chem 271: 24151–6.PubMedGoogle Scholar
  66. Parker, M.G. 1993. Steroid and related receptors. Curr Opin Cell Biol 5: 499–504.PubMedGoogle Scholar
  67. Patient, R.K. and J.D. McGhee. 2002. The GATA family (vertebrates and invertebrates). Curr Opin Genet Dev 12: 416–22.PubMedGoogle Scholar
  68. Perez-Stable, C.M., A. Pozas, and B.A. Roos. 2000. A role for GATA transcription factors in the androgen regulation of the prostate-specific antigen gene enhancer. Mol Cell Endocrinol 167: 43–53.PubMedGoogle Scholar
  69. Perissi, V. and M.G. Rosenfeld. 2005. Controlling nuclear receptors: the circular logic of cofactor cycles. Nat Rev Mol Cell Biol 6: 542–54.PubMedGoogle Scholar
  70. Prefontaine, G.G., M.E. Lemieux, W. Giffin, C. Schild-Poulter, L. Pope, E. LaCasse, P. Walker, and R.J. Hache. 1998. Recruitment of octamer transcription factors to DNA by glucocorticoid receptor. Mol Cell Biol 18: 3416–30.PubMedGoogle Scholar
  71. Ramakrishnan, V., J.T. Finch, V. Graziano, P.L. Lee, and R.M. Sweet. 1993. Crystal structure of globular domain of histone H5 and its implications for nucleosome binding. Nature 362: 219–23.PubMedGoogle Scholar
  72. Remenyi, A., H.R. Scholer, and M. Wilmanns. 2004. Combinatorial control of gene expression. Nat Struct Mol Biol 11: 812–5.PubMedGoogle Scholar
  73. Rhodes, D.R., J. Yu, K. Shanker, N. Deshpande, R. Varambally, D. Ghosh, T. Barrette, A. Pandey, and A.M. Chinnaiyan. 2004. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6: 1–6.PubMedGoogle Scholar
  74. Ryan, A.K. and M.G. Rosenfeld. 1997. POU domain family values: flexibility, partnerships, and developmental codes. Genes Dev 11: 1207–25.PubMedGoogle Scholar
  75. Sato, N., M.D. Sadar, N. Bruchovsky, F. Saatcioglu, P.S. Rennie, S. Sato, P.H. Lange, and M.E. Gleave. 1997. Androgenic induction of prostate-specific antigen gene is repressed by protein–protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaP. J Biol Chem 272: 17485–94.PubMedGoogle Scholar
  76. Scher, H.I. and C.L. Sawyers. 2005. Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis. J Clin Oncol 23: 8253–61.PubMedGoogle Scholar
  77. Segawa, T., M.E. Nau, L.L. Xu, R.N. Chilukuri, M. Makarem, W. Zhang, G. Petrovics, I.A. Sesterhenn, D.G. McLeod, J.W. Moul, M. Vahey, and S. Srivastava. 2002. Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells. Oncogene 21: 8749–58.PubMedGoogle Scholar
  78. Seth, A. and D.K. Watson. 2005. ETS transcription factors and their emerging roles in human cancer. Eur J Cancer 41: 2462–78.PubMedGoogle Scholar
  79. Shaffer, P.L., A. Jivan, D.E. Dollins, F. Claessens, and D.T. Gewirth. 2004. Structural basis of androgen receptor binding to selective androgen response elements. Proc Natl Acad Sci U S A 101: 4758–63.PubMedGoogle Scholar
  80. Shang, Y., M. Myers, and M. Brown. 2002. Formation of the androgen receptor transcription complex. Mol Cell 9: 601–10.PubMedGoogle Scholar
  81. Singh, D., P.G. Febbo, K. Ross, D.G. Jackson, J. Manola, C. Ladd, P. Tamayo, A.A. Renshaw, A.V. D'Amico, J.P. Richie, E.S. Lander, M. Loda, P.W. Kantoff, T.R. Golub, and W.R. Sellers. 2002. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 1: 203–9.PubMedGoogle Scholar
  82. So, A.Y., C. Chaivorapol, E.C. Bolton, H. Li, and K.R. Yamamoto. 2007. Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor. PLoS Genet 3: e94.PubMedGoogle Scholar
  83. Takayama, K., K. Kaneshiro, S. Tsutsumi, K. Horie-Inoue, K. Ikeda, T. Urano, N. Ijichi, Y. Ouchi, K. Shirahige, H. Aburatani, and S. Inoue. 2007. Identification of novel androgen response genes in prostate cancer cells by coupling chromatin immunoprecipitation and genomic microarray analysis. Oncogene 26: 4453–63.PubMedGoogle Scholar
  84. Tomlins, S.A., D.R. Rhodes, S. Perner, S.M. Dhanasekaran, R. Mehra, X.W. Sun, S. Varambally, X. Cao, J. Tchinda, R. Kuefer, C. Lee, J.E. Montie, R.B. Shah, K.J. Pienta, M.A. Rubin, and A.M. Chinnaiyan. 2005. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310: 644–8.PubMedGoogle Scholar
  85. Tomlins, S.A., R. Mehra, D.R. Rhodes, L.R. Smith, D. Roulston, B.E. Helgeson, X. Cao, J.T. Wei, M.A. Rubin, R.B. Shah, and A.M. Chinnaiyan. 2006. TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer. Cancer Res 66: 3396–400.PubMedGoogle Scholar
  86. Tomlins, S.A., B. Laxman, S.M. Dhanasekaran, B.E. Helgeson, X. Cao, D.S. Morris, A. Menon, X. Jing, Q. Cao, B. Han, J. Yu, L. Wang, J.E. Montie, M.A. Rubin, K.J. Pienta, D. Roulston, R.B. Shah, S. Varambally, R. Mehra, and A.M. Chinnaiyan. 2007. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 448: 595–9.PubMedGoogle Scholar
  87. Tsai, M.J. and B.W. O'Malley. 1994. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63: 451–86.PubMedGoogle Scholar
  88. van Steensel, B. 2005. Mapping of genetic and epigenetic regulatory networks using microarrays. Nat Genet 37 Suppl: S18–24.PubMedGoogle Scholar
  89. Velasco, A.M., K.A. Gillis, Y. Li, E.L. Brown, T.M. Sadler, M. Achilleos, L.M. Greenberger, P. Frost, W. Bai, and Y. Zhang. 2004. Identification and validation of novel androgen-regulated genes in prostate cancer. Endocrinology 145: 3913–24.PubMedGoogle Scholar
  90. Verrijdt, G., A. Haelens, and F. Claessens. 2003. Selective DNA recognition by the androgen receptor as a mechanism for hormone-specific regulation of gene expression. Mol Genet Metab 78: 175–85.PubMedGoogle Scholar
  91. Verrijdt, G., T. Tanner, U. Moehren, L. Callewaert, A. Haelens, and F. Claessens. 2006. The androgen receptor DNA-binding domain determines androgen selectivity of transcriptional response. Biochem Soc Trans 34: 1089–94.PubMedGoogle Scholar
  92. Verrijzer, C.P. and P.C. Van der Vliet. 1993. POU domain transcription factors. Biochim Biophys Acta 1173: 1–21.PubMedGoogle Scholar
  93. Wang, Q., D. Sharma, Y. Ren, and J.D. Fondell. 2002. A coregulatory role for the TRAP-mediator complex in androgen receptor-mediated gene expression. J Biol Chem 277: 42852–8.PubMedGoogle Scholar
  94. Wang, Q., J.S. Carroll, and M. Brown. 2005. Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Mol Cell 19: 631–42.PubMedGoogle Scholar
  95. Wang, Q., W. Li, X.S. Liu, J.S. Carroll, O.A. Janne, E.K. Keeton, A.M. Chinnaiyan, K.J. Pienta, and M. Brown. 2007. A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol Cell 27: 380–92.PubMedGoogle Scholar
  96. Wasylyk, B., S.L. Hahn, and A. Giovane. 1993. The Ets family of transcription factors. Eur J Biochem 211: 7–18.PubMedGoogle Scholar
  97. Wei, C.L., Q. Wu, V.B. Vega, K.P. Chiu, P. Ng, T. Zhang, A. Shahab, H.C. Yong, Y. Fu, Z. Weng, J. Liu, X.D. Zhao, J.L. Chew, Y.L. Lee, V.A. Kuznetsov, W.K. Sung, L.D. Miller, B. Lim, E.T. Liu, Q. Yu, H.H. Ng, and Y. Ruan. 2006. A global map of p53 transcription-factor binding sites in the human genome. Cell 124: 207–19.PubMedGoogle Scholar
  98. Wright, M.E., M.J. Tsai, and R. Aebersold. 2003. Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells. Mol Endocrinol 17: 1726–37.PubMedGoogle Scholar
  99. Yu, Y.P., D. Landsittel, L. Jing, J. Nelson, B. Ren, L. Liu, C. McDonald, R. Thomas, R. Dhir, S. Finkelstein, G. Michalopoulos, M. Becich, and J.H. Luo. 2004. Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol 22: 2790–9.PubMedGoogle Scholar
  100. Yuan, X., M.L. Lu, T. Li, and S.P. Balk. 2001. SRY interacts with and negatively regulates androgen receptor transcriptional activity. J Biol Chem 276: 46647–54.PubMedGoogle Scholar
  101. Yuan, X., T. Li, H. Wang, T. Zhang, M. Barua, R.A. Borgesi, G.J. Bubley, M.L. Lu, and S.P. Balk. 2006. Androgen receptor remains critical for cell-cycle progression in androgen-independent CWR22 prostate cancer cells. Am J Pathol 169: 682–96.PubMedGoogle Scholar
  102. Zegarra-Moro, O.L., L.J. Schmidt, H. Huang, and D.J. Tindall. 2002. Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells. Cancer Res 62: 1008–13.PubMedGoogle Scholar
  103. Zhou, Y., K.C. Lim, K. Onodera, S. Takahashi, J. Ohta, N. Minegishi, F.Y. Tsai, S.H. Orkin, M. Yamamoto, and J.D. Engel. 1998. Rescue of the embryonic lethal hematopoietic defect reveals a critical role for GATA-2 in urogenital development. EMBO J 17: 6689–700.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Division of Molecular and Cellular OncologyDepartment of Medical Oncology Dana-Farber Cancer Institute and Harvard Medical School>USA

Personalised recommendations